Identity
- Trade Name
- FarrowWrap® Lite EUDAMED
- Device Name
- FarrowWrap® Lite LG FT TH KN EUDAMED
- Model / Reference
- 76652-03 EUDAMED
Identifiers
- Primary DI / UDI-DI
- 04042809538045 EUDAMED
- Basic UDI-DI
- 4042809400389109X EUDAMED
- EMDN Code
- M030405 COMPRESSION STOCKINGS EUDAMED
Classification
- Device Class
- Class I EUDAMED
- Market of Registration
- Netherlands EUDAMED
Clinical & Handling
Sterile
No
EUDAMED
Implantable
No
EUDAMED
Reusable
No
EUDAMED
Contains Latex
No
EUDAMED
Reprocessed
No
EUDAMED
CMR Substance
No
EUDAMED
Human-derived
No
EUDAMED
Human Tissues
No
EUDAMED
Animal Tissues
No
EUDAMED
Endocrine Disruptor
No
EUDAMED
Administering Medicine
No
EUDAMED
Measuring Function
No
EUDAMED
Incorporates Medicinal Product
No
EUDAMED
Category: Compression/pressure sock/stocking, single-use
FarrowWrap® Lite by Bsn Medical, Inc. — Class I — MDR — listed in EUDAMED — regulatory data on deviCERTS
Similar devices
Also classified as Compression/pressure sock/stocking, single-use.
- VenoTrain soft — Bauerfeind GmbH & Co. · Class II
- VenoTrain soft S — Bauerfeind GmbH & Co. · Class II
- MEDI — MEDI MANUFACTURING, INC. · Class II
- MEDI — MEDI MANUFACTURING, INC. · Class II
- VenoTrain micro — Bauerfeind GmbH & Co. · Class II
- VenoTrain soft, AG, Top band silicone micro dots, Ccl2, open toe, L Plus short, Cream — Bauerfeind AG · Class I
- VARISAN TOP COTTON — CIZETA MEDICALI S.P.A. · Class I
- MEDI — MEDI MANUFACTURING, INC. · Class II
Authorization Coverage (European Union — 27 member states)
Regulatory Authorizations
European Union Active
CE/MDR
| Source | Region | Type | Cert / Approval No. | Class | Status |
|---|---|---|---|---|---|
| EUDAMED | European Union | CE/MDR | 4042809400389109X | Class I | Active |
Is this your device? Claim it to add documentation and request validation.
Manufacturer
- Manufacturer
- BSN Medical Inc.
- EUDAMED SRN
- US-MF-000019174
- Authorised Representative
- BSN medical GmbH DE-AR-000005791
Sources (1)
- EUDAMED bf0f5f07-30d4-4d55-a3c5-2b5b0e232f96 61 fields · synced Jul 8, 2026